Viewing Study NCT02612194


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT02612194
Status: TERMINATED
Last Update Posted: 2022-11-03
First Post: 2015-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Sponsor: Wake Forest University Health Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2019-09-17
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-21
Completion Date Type: ACTUAL
First Submit Date: 2015-11-19
First Submit QC Date: None
Study First Post Date: 2015-11-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-09-16
Results First Submit QC Date: None
Results First Post Date: 2021-06-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-11-01
Last Update Post Date: 2022-11-03
Last Update Post Date Type: ACTUAL